Expertise in
22
conditions

Raja Ramachandran

Chandigarh, CH, IN 
Expertise in
22
conditions
Chandigarh, CH, IN 

Overview

Raja Ramachandran practices practicing medicine in Chandigarh, India.

Ramachandran is highly rated in 22 conditions, according to our data. Their clinical expertise encompasses Membranous Nephropathy, Glomerulonephritis, Nephrotic Syndrome, Kidney Transplant, and Nephrectomy.

They are actively involved in clinical research, co-authoring 234 peer reviewed articles and participating in 2 clinical trials.

Locations

Chandigarh, CH, India
Other Locations
PB, India
New Delhi, DL, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Enrollment Status: Completed
Publish Date: September 23, 2021
Intervention Type: Drug
Study Phase: Not Applicable
View 1 Less Clinical Trial

234 Total Publications

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.
Journal: JAMA
Published: June 04, 2026

Frequently Asked Questions about Raja Ramachandran

Is Raja Ramachandran a top-rated expert for Membranous Nephropathy?

MediFind is an objective health platform that identifies experts based on real-world data. Raja Ramachandran is classified as an Elite expert for Membranous Nephropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Raja Ramachandran participate in research or clinical trials?

Yes. Raja Ramachandran has published 234 articles and abstracts on conditions like Membranous Nephropathy. You can view a list of Raja Ramachandran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ramachandran's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 49 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile